Self-assess your hair transplant candidacy before booking. Covers donor density thresholds, absolute contraindications, smoking cessation timelines, and Istanbul provider verification.
Last reviewed: 2026-05-06
12 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Key takeaways
A stable donor area (back and sides of scalp) is the primary requirement — transplant cannot succeed without it.
Eight conditions are absolute contraindications: DUPA, active scarring alopecias, active alopecia areata, unstable loss, insufficient donor hair, age under ~25, unrealistic expectations, and uncontrolled medical conditions.
Donor area miniaturization above 35% may be a contraindication; above 15% is a warning sign requiring specialist evaluation.
Verify your surgeon's credentials through the ISHRS find-a-doctor tool before committing — this applies to Istanbul clinics and any other provider.
This checklist screens for education only; a clinical examination with dermoscopy is required to confirm candidacy.
What Makes Someone a Candidate for Hair Transplant Surgery
Not everyone with hair loss is a suitable candidate for hair transplant surgery. The core evaluation focuses on the stability of your hair loss pattern, the health of your donor area, and your general medical condition. For broader context on hair loss types and treatment options, see the Hair Resources Hub.
The American Society of Plastic Surgeons identifies "good hair growth at the back and sides of the head" as the primary criterion — hair from these zones serves as the donor supply for the entire procedure.
The foundational principle is donor dominance: transplanted follicles retain the characteristics of the tissue they came from. Hair relocated from the back and sides of the scalp tends to maintain its resistance to the hormonal drivers of androgenetic alopecia even after relocation to thinning areas. This is why a stable donor area is the non-negotiable foundation of candidacy.
A hair transplant redistributes existing hair — it does not create new hair. The supply is finite. That is why donor area evaluation is the starting point and the endpoint of any candidacy assessment.
General Candidacy Range
For men, Norwood/Hamilton Classes 2–5 represent the typical candidacy range. For women, Ludwig Grade I–II is common. Donor density of more than 60 follicular units per cm² is generally needed for a meaningful cosmetic result — below this threshold, the supply may be insufficient to justify the procedure.
Hair color, texture, and waviness can affect the cosmetic result. Fine hair (under 60 microns) provides more limited coverage than coarse hair, and candidates with these characteristics should discuss realistic expectations with their surgeon.
The Donor Area and Why It Is Critical
The donor area must be examined by a specialist using dermoscopy or densitometry — visual inspection alone is not sufficient. Donor area miniaturization above 15% is a warning sign; above 35% may constitute a contraindication depending on clinical judgment.
Patients with diffuse unpatterned alopecia (DUPA) may not have a stable donor zone at all. In DUPA, the androgenetic process affects the back and sides diffusely, eliminating the stable supply that transplant requires. A surgeon who skips dermoscopic evaluation may miss this.
Conditions That May Disqualify or Delay a Transplant
Absolute Contraindications — Do Not Proceed Without Resolution
These eight conditions mean transplant is likely to fail, cause harm, or produce unsatisfying results. A surgeon who identifies these during consultation should decline surgery. A provider who proceeds anyway is a red flag.
Diffuse Unpatterned Alopecia (DUPA) — The donor area is affected by the same androgenetic process that causes thinning. No stable zone exists. Transplant is unlikely to succeed. Medical therapy is the appropriate path.
Active Cicatricial (Scarring) Alopecias — Including Lichen Planopilaris (LPP), Central Centrifugal Cicatricial Alopecia (CCCA), and Discoid Lupus Erythematosus (DLE). Surgery can exacerbate disease activity, and transplanted hair may be lost to ongoing scarring. Requires 2+ years of confirmed inactivity with biopsy documentation.
Active Alopecia Areata — The autoimmune condition may attack transplanted follicles. Requires extended disease inactivity before consideration.
Unstable or Rapidly Progressing Hair Loss — When loss is still advancing rapidly, shock loss — permanent loss of native hair from surgical trauma — is a significant risk. This is especially true when recipient-area miniaturization exceeds 15%.
Insufficient Donor Hair — Not enough stable hair exists to achieve meaningful cosmetic improvement.
Very Young Patients (under ~25) — The hair loss pattern may not be established; operating early risks depleting a limited donor supply before the full extent of loss is known. Age 25 is a commonly cited general threshold, though individual clinical judgment applies.
Unrealistic Expectations — After thorough counseling, if the patient cannot align expectations with clinical reality, the surgeon should decline.
Medically Unfit — Uncontrolled hypertension (bleeding risk), uncontrolled diabetes (impaired healing and infection risk), bleeding disorders, or immune deficiency states.
Relative Contraindications — Pause and Investigate
These do not automatically disqualify but require optimization or further investigation:
Donor area miniaturization: >15% is a warning sign; >35% may be a contraindication depending on clinical judgment.
Active scalp conditions: Seborrheic dermatitis or psoriasis must be controlled before surgery. Daily itching, burning, redness, or tenderness warrants biopsy to rule out scarring alopecia.
Women generally: Diffuse thinning requires workup to differentiate female pattern hair loss from telogen effluvium, thyroid issues, iron deficiency, or hormonal causes. Hormonal evaluation may be warranted.
Frontal Fibrosing Alopecia (FFA): Increasingly prevalent, affects eyebrows first, has an aggressive scarring pattern. Requires specialist evaluation before any surgery.
Pre-Consultation Checklist — What to Verify Before Pursuing a Transplant
Use this checklist to prepare for your consultation and identify issues that may affect your candidacy. This is educational screening, not diagnosis — clinical confirmation is required.
Medical History Self-Assessment
[ ] Do you have any active scalp symptoms — redness, scaling, itching, burning, or tenderness?
[ ] Have you been diagnosed with any scarring alopecia (LPP, CCCA, DLE)?
[ ] Have you experienced patchy hair loss beyond pattern areas (alopecia areata)?
[ ] Do you have uncontrolled high blood pressure or diabetes?
[ ] Do you have a bleeding disorder or take blood-thinning medications?
[ ] Are you a smoker, or have you smoked in the past 3 months?
[ ] Have you been diagnosed with trichotillomania or Body Dysmorphic Disorder?
[ ] Is your hair loss still progressing rapidly — noticeable change in 6 months or less?
[ ] Who performs each step: harvesting, site creation, implantation? (The surgeon should perform key steps — not delegate to technicians unsupervised.)
[ ] Clear post-operative follow-up plan established across borders
[ ] Complication escalation plan documented with local emergency contacts
[ ] Smoking cessation: Complete 3–6 weeks before surgery and post-operatively
[ ] Blood-thinning medications: Confirmed discontinuation 72–96 hours before surgery — coordinate with the prescribing physician; do not stop without medical guidance
[ ] Herbal supplements: Discontinued at least 1 week before surgery (many potentiate bleeding)
Questions That Separate Thorough Practitioners from Shortcuts
These questions help you identify providers who do rigorous evaluation versus those who proceed without adequate assessment.
Ask these at every consultation before committing:
What is my hair loss diagnosis, and what is the stability of my pattern?
What is my donor area density — have you examined it with dermoscopy or densitometry? (Not visual inspection alone.)
What are my options if I am NOT a candidate today?
What treatment would you recommend to stabilize my loss before considering surgery?
What is your experience with my specific hair and skin type?
Who performs each step of the procedure — harvesting, site creation, implantation? (The surgeon should perform key steps; delegation to technicians unsupervised is a red flag.)
What is your complication rate, and how do you handle post-operative emergencies?
Can I speak with previous patients or see standardized before/after photographs?
What is the realistic outcome for my specific case — and what will it NOT achieve?
Will I need additional procedures, and what is the long-term treatment plan?
No discussion of medical management alongside surgical options
No scalp biopsy offered when scalp abnormalities are present
Rushed consultation without thorough history
Dismissal of your questions or concerns
If You Have Post-Op Concerns
If you experience signs of infection (increasing redness, warmth, pus, fever), sudden heavy bleeding, or any urgent symptoms after a hair transplant procedure, seek immediate medical attention at a local emergency facility. Do not wait for a scheduled follow-up appointment.
Use this checklist to prepare, but confirm everything with a qualified specialist who has physically examined your scalp. Candidacy cannot be determined from a checklist alone.
Start Your Plan to connect with vetted Istanbul hair transplant providers for a credential-verified consultation.
References
1.True V et al.. “Is Every Patient of Hair Loss a Candidate for Hair Transplant?.” Indian Journal of Plastic Surgery / NIH PMC. 2021. Accessed 2026-04-27.https://pmc.ncbi.nlm.nih.gov/articles/PMC8719975/
5.Brinks AL, Needle CD, et al.. “Hair Transplant: Patient Candidacy, Medical Optimization, and Surgical Considerations.” International Journal of Dermatology. 2026. Accessed 2026-04-27.https://pubmed.ncbi.nlm.nih.gov/40660483/
8.Vañó-Galván et al.. “International Expert Consensus on Pre- and Post-Hair Transplantation Care.” Journal of Dermatological Treatment. 2023. Accessed 2026-04-27.https://pubmed.ncbi.nlm.nih.gov/37477225/
External links are provided for educational reference. Verify guidance with qualified clinicians and primary sources where appropriate.
